Clinical News

Guselkumab Ranked Highest Overall in Skin Clearance for Psoriatic Arthritis

32 minutes ago

By Armand Butera

The analysis also showed guselkumab showed positive joint efficacy among all published advanced therapies approved and currently under regulatory review.

Out-of-Pocket Spending Remains High for Chronic Hepatitis B Treatments

33 minutes ago

By Kenny Walter

As the number of entecavir manufacturers increased from 1-11, the NADAC decreased from $30.12 to $1.93 per 0.5 mg tablet.

USPSTF Updates Screening Guidelines for Atrial Fibrillation

1 hour ago

By Connor Iapoce

The new guidelines conclude that current evidence is insufficient to assess the balance of benefits and harms of screening for AF in adults ≥50 years.

FDA Clears Phase 2B Study Testing LSD for Anxiety

1 hour ago

By Kenny Walter

MindMed will now move forward with the 200 patient randomized, placebo-controlled study.

Future Directions in the Treatment of Plaque Psoriasis

3 hours ago

By Brad Glick, DO, MPH

Key opinion leaders conclude their discussion on plaque psoriasis by commenting on the potential for research into the genetic origin of disease, possible biomarkers, and treatment options with greater efficacy.

Crisis Point - Obesity Crisis

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

Conference Coverage

View All >>

Better Minority Enrollment Needed in UK Multiple Myeloma Trials

December 14, 2021

By Kenny Walter

The enrollment distribution was consistent by ethnicity over the course of 18 years, with no change in diversity over time despite there being an increase in the UK in the minority population.

Fuad El Rassi, MD, Tracks COVID-19 and Sickle Cell Disease For a Year

December 14, 2021

By Giuliana Grossi

Of the SCD patients who contracted COVID-19, 49% of them visited the Grady Comprehensive Sickle Cell center because of a vaso-occlusive event.

Identifying Distinct Cognitive Profiles Of Adults With SCD May Reduce Morbidity

December 14, 2021

By Connor Iapoce

Data show patients with sickle cell disease identified by distinct cognitive profile should have neurorehabilitation tailored to each unique profile.

Voxelotor May Improve Exercise Capacity In Patients With Sickle Cell Anemia

December 14, 2021

By Connor Iapoce

After 2 months of voxelotor treatment, all patients with sickle cell anemia perceived global improvement, but peak VO2 did not change in 8 of 9 patients.

Video Series

View All >>

Hybrid Artificial Insulin Pump Systems for T2DM

Integrating Continuous Glucose Monitoring Systems into Clinical Practice

Managing Insomnia: Addressing Shortcomings in OTC Medications

Use of Mind and Body Practices to Manage Insomnia

Introduction of a New Class of Agents: TYK2 Inhibitors

Emerging Topical Therapy Options for Plaque Psoriasis

Role of HCPs in the Management of Vitiligo

Real-World Impact of Vitiligo

Anti-VEGF Agents and Diabetic Retinopathy Severity Score

Maintenance Treatment for Diabetic Macular Edema